Study |
Purpose |
Patient Criteria |
Current number of trials |
Asthma |
Dose range finding study for a new inhaled corticosteroid administered as a dry powder in adults and adolescents with asthma. |
12 years and older with asthma |
2 |
Acute Tonsillitis/
Pharyngitis |
Evaluate the effectiveness of an antibiotic against step throat in children. |
Adults aged 6 months to 12 years of age |
1 |
Acute Tonsillitis/
Pharyngitis |
Evaluate the effectiveness of an antibiotic against step throat in adults. |
Adults aged 13 years and older |
1 |
Insomnia Associated with ADHD |
Evaluate the safety and efficacy of an oral medication to treat symptoms of insomnia associated with ADHD in children. |
6 yrs.- 17yrs. old |
1 |
Sleep
Maintenance Insomnia |
Evaluate the safety and efficacy of an oral medication for the treatment of sleep-maintenance insomnia in adults. |
18yrs. and older |
1 |
Attention Deficit Hyperactivity Disorder in Adults |
Evaluate the efficacy and safety of oral non-stimulant medication in the treatment of ADHD in adults |
18-65 years old patients with ADHD |
1 |
Attention Deficit Hyperactivity Disorder |
Evaluate the safety and efficacy of oral non-stimulant medication in adults with ADHD. Examination of impact of treatment on family functioning |
18 yrs. or older patients with a family (living with a spouse or significant other for at least 3 months) and have a biological child of age 6-12 yrs. |
1 |
Attention Deficit Hyperactivity Disorder |
Evaluate the safety and efficacy of an oral stimulant medication with an extended duration of action in adults with ADHD. |
|
1 |
Meningitis Combination
Vaccine Trial |
Evaluate efficacy and safety of a combination vaccine against meningitis and Haemophilus Influenzae. |
Toddlers 6-12 weeks of age at the time of their first vaccination |
1 |
Herpes Vaccine Trial |
Evaluate efficacy and safety of Herpes Simplex Virus vaccines in adolescent females. |
Adolescent females |
1 |
Diabetes Trial |
Evaluate efficacy and safety of an oral medication in combination with Glyburide in subjects with Type II Diabetes who have inadequate control with Glyburide alone. |
Adults 18-77 years of age |
1 |
